Abstract:
SLU-PP-332 the exercise mimetic. Exercise mimetics are compounds designed to copy the molecular effects of exercise. One of the most promising strategies targets estrogen‑related receptors (ERRs) are nuclear proteins that turn on metabolism genes. These drive endurance‑like adaptations in muscle, liver, and heart.
What’s an “exercise mimetic”?
Exercise mimetic: a compound such as SLU-PP-332 triggers the same signaling pathways activated by endurance training without physical exertion. It can have profound effects in combating metabolic disorders and obesity. While mimetics create “exercise‑like signals,” they are not a replacement for movement. Physical activity is still necessary for optimal results. Potential candidates include the energy sensor AMPK (a cellular fuel gauge) and the ERR family (ERRα/β/γ). These are transcription factors that upregulate genes for mitochondria and fat burning.
Estrogen‑related receptors
Estrogen‑related receptors (ERRs) are orphan nuclear receptors (no known natural hormone ligand). They control genes for mitochondrial biogenesis (making more mitochondria, the cell’s power stations) and oxidative phosphorylation (using oxygen to make ATP, the cell’s energy currency). ERRα, which is heavily influenced with SLU-PP-332, is highly expressed in high‑demand tissues (skeletal muscle, heart, brain, liver). It is a master regulator of aerobic metabolism, often working with the coactivator PGC‑1α (a master switch for mitochondrial programs).
Key term refreshers
• Mitochondrial biogenesis: building new mitochondria to increase energy capacity.
• Oxidative phosphorylation: the oxygen‑using pathway that manufactures ATP.
• PGC‑1α: a co‑regulator that amplifies endurance‑style gene programs.
Why target ERRs to “mimic” training?
Endurance exercise induces a shift where mitochondria promote fatty acid oxidation; this means burning fat for energy. Activating ERRs can enhance fatigue resistance and turn on genes that promote fat transport. In addition, they encourage oxidation and increase respiratory capacity. Since ERRs, such as SLU-PP-332, use the same metabolic pathways as muscles to call for energy, their effects are most noticeable in skeletal muscle.
SLU-PP-332 the Exercise Mimetic
SLU-PP-332, the exercise mimetic, is a pan‑ERR agonist (drug that activates ERRα/β/γ). It was created to trigger an endurance‑like gene signature and performance benefits in mice. In peer‑reviewed studies, SLU-PP-332 increased oxidative muscle fibers and enhanced treadmill endurance. It also shifted whole‑body fuel use toward fats, shown by a lower respiratory exchange ratio, RER—the CO₂/O₂ ratio used to infer fat vs. carb burning.
What’s the clinical promise?
ERRs sit atop energy programs, making compounds like SLU-PP-332 potential candidates. These compounds could address diseases marked by metabolic inflexibility. This compound could correct diseases like obesity, insulin resistance, muscle wasting, and even certain forms of heart failure. The biggest challenge to realizing this outcome is overcoming limited safety information and selectivity hurdles. Successfully addressing these will enable more clinical trials.
Bottom line:
ERR‑targeted exercise mimetics, such as SLU-PP-332, won’t replace training for healthy people, but they could one day serve patients who can’t exercise enough to benefit—pending rigorous human trials.
Works cited
https://www.acs.org/pressroom/presspacs/2024/march/mimicking-exercise-with-a-pill.html
https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2019.00206/full
https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2019.00206/full
https://pmc.ncbi.nlm.nih.gov/articles/PMC11584170/
https://pmc.ncbi.nlm.nih.gov/articles/PMC10801787/
https://www.acs.org/pressroom/presspacs/2024/march/mimicking-exercise-with-a-pill.html
“For education only; not medical advice; SLU‑PP‑332 is an investigational research compound with no human approval.”